The American journal of psychiatry
The American journal of psychiatry
Audio Summaries
Every issue of The American journal of psychiatry moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
The American journal of psychiatry covers research in these specialties.
Recent summaries
The latest articles summarized from The American journal of psychiatry.
GLP-1 Receptor Agonists in Psychotic Disorders: Mechanistic Convergence and Therapeutic Implications for Brain and Metabolic Health.
Nov 18, 2026
This systematic review and narrative synthesis asks whether GLP-1 receptor agonists, which act on glucose, gut-brain, inflammatory, and reward pathways, could address the metabolic and neuropsychiatric burden of psychotic disorders. The authors find the clearest benefit for antipsychotic-associated weight gain and cardiometabolic risk, with suggestive but inconclusive effects on alcohol and nicotine use and no consistent improvement in psychotic symptoms, cognition, or functioning. They conclude that GLP-1RAs are a mechanistically grounded strategy for cardiometabolic burden in psychotic disorders, though current trials are small, short, and heterogeneous.
Growth Differentiation Factor 15 as a Body-Brain Stress Signal in Major Depression and Insulin Resistance.
Nov 18, 2026
This study asked whether GDF15, a stress-induced cytokine linking peripheral and central energy metabolism, is elevated in major depressive disorder (MDD) and insulin resistance, and whether it predicts depressive symptom persistence. In 190 MDD patients and 183 controls, both MDD and insulin resistance were associated with higher GDF15, and GDF15 tracked with depression severity, childhood trauma, and perceived stress, with baseline levels predicting symptom persistence in MDD patients. These associations were partly replicated in an independent sample of medication-free MDD patients, positioning GDF15 as a candidate biomarker at the intersection of mental and metabolic health.
Lithium for Suicide Prevention: Umbrella Review and Meta-Analysis.
Nov 18, 2026
This umbrella review and meta-analysis asked whether lithium reduces suicide-related outcomes in patients with psychiatric disorders, based on randomized trial evidence from 20 trial publications (3,675 participants). For completed suicide, the pooled estimate favored lithium but was borderline non-significant (OR=0.39, 95% CI 0.15–1.00), with the signal being sensitive to the estimator used and concentrated in trials of mixed mood-disorder populations; no significant effects were found for suicide attempts, self-harm, mortality, or composite outcomes, and GRADE certainty was low to very low. The authors conclude that the evidence is more uncertain than earlier syntheses suggested, so lithium remains an option when clinically indicated, but adequately powered trials are needed.
Targeted Use of Kudzu for Binge Drinking Among Adults With Alcohol Use Disorder: A Phase 2b Randomized Trial.
Nov 4, 2026
This phase 2b double-blind, placebo-controlled trial asked whether as-needed kudzu extract (2 g taken on anticipated binge-drinking days), combined with weekly counseling, reduces binge drinking in adults with alcohol use disorder. Among 120 randomized participants, kudzu reduced binge-drinking days compared with placebo (IRR=0.73 intention-to-treat; IRR=0.58 among those who took it at least 2.7 days per week), with reductions persisting at 3-month follow-up and no serious kudzu-related adverse events. The authors conclude that targeted kudzu use may be a helpful pharmacologic option for binge drinking in AUD.
Mapping Individual Brain Deviations in ICD-11 Catatonia: Normative Modeling of Structural and Functional MRI Across Two Independent Cohorts.
Nov 4, 2026
This study used hierarchical Bayesian normative modeling on structural and resting-state fMRI from two independent cohorts (280 patients with mood disorders or schizophrenia spectrum disorders) to ask whether ICD-11 catatonia is linked to individual-level brain deviations that are reproducible across sites and diagnoses. Catatonia was associated with ventricular enlargement and cortical thinning in the left dorsal posterior cingulate and insular cortices across both cohorts, supporting a transdiagnostic model involving motor-salience circuits. Functional connectivity reductions were only nominally significant and did not survive multiple-comparison correction, so the functional evidence remains preliminary.
Changing Patterns of Alcohol and Cannabis Acute Care Admissions by Age in the United States, 2016-2023.
Nov 4, 2026
This retrospective cohort study of commercially insured and Medicaid enrollees examined how the share of substance-related emergency and inpatient encounters involving alcohol or cannabis changed by age from 2016 to 2023. The authors found divergent patterns: alcohol-related admissions rose most among adults aged 25-44, while cannabis-related admissions grew fastest among young adults aged 19-24 and adolescents, with increases in psychosis and vomiting presentations. Cannabis predominated among adolescents and young adults, whereas alcohol predominated among older adults.
Dose-Response Patterns and Pathways Linking Migration-Related Stigma and Mental Health.
Nov 4, 2026
This study examines whether migration-related stigma, conceptualized as symbolic violence, explains mental health disparities among Asian, Black, and Latinx immigrant-origin adults in the U.S. Using a national quota sample of 908 participants and regression models, the authors found that racial-ethnic differences in psychological distress and PTSD symptoms were reduced once immigration factors and stigma were accounted for, with interpersonal and intrapersonal stigma (discrimination, social exclusion, shame, devaluation) being the strongest predictors. A cumulative stigma index showed a dose-response pattern, where each additional stigma exposure was linked to higher symptom levels.
Instrumental Support Calls vs. Caring Contacts Texts to Prevent Suicide in Adolescents and Adults: The SPARC Randomized Clinical Trial.
Oct 28, 2026
This randomized trial (SPARC) asked whether follow-up suicide care delivered as instrumental support phone calls or two-way Caring Contacts texts better reduces suicidal ideation and behavior among adolescents and adults discharged from emergency departments or primary care after a suicide risk screen. Among adults, Caring Contacts was associated with higher suicidal ideation/behavior scores at 6 months than instrumental support calls, while among adolescents, Caring Contacts led to lower scores at 12 months. The authors conclude that the optimal follow-up approach may depend on age, with adolescents benefiting from longer-term text-based connection and adults benefiting from earlier, more intensive instrumental support.
Effects of External Trigeminal Nerve Stimulation on Neurocognitive Functioning in Children and Adolescents With ADHD: A Phase 2b Multicenter Randomized Controlled Trial.
Oct 28, 2026
This multicenter, double-blind randomized trial asked whether 4 weeks of nightly external trigeminal nerve stimulation (TNS) improves cognition, autonomic nervous system regulation, and head motion in 150 youths with ADHD (ages 8-18) compared with sham stimulation. Intention-to-treat analyses found no significant differences between active and sham TNS on any cognitive or physiological outcome at 4 weeks or on cognitive measures at 6-month follow-up. The authors conclude that TNS does not appear to enhance neurocognitive or autonomic functioning in youths with ADHD, which does not support its use for those purposes.
Transcriptomic Network Analysis Reveals Trauma Type- and Ancestry-Related Heterogeneity in Posttraumatic Stress Disorder.
Oct 28, 2026
This study used network analysis of blood transcriptomes from 466 pregnant women in South Africa to ask whether gene expression patterns in PTSD and MDD reflect biological heterogeneity. The authors found that transcriptomic signatures predicted trauma exposure profiles (childhood adversity, intimate partner violence, recent life stress) and ancestry with moderate accuracy (AUROC ~0.61-0.69), but predicted PTSD or MDD diagnosis at near-chance levels (AUROC ~0.52). These results suggest that exposure-informed stratification may complement traditional diagnostic categories for capturing biologically meaningful heterogeneity.
